Vadim M.

Vadim M. is the current Executive Director of Translational Biology at Rigel Pharmaceuticals Inc. Vadim has been instrumental in the development and repurposing of drugs for treating patients with COVID-19. Additionally, Vadim has a strong background in biochemistry and has conducted research in various disease areas to improve the health and quality of life of patients. Vadim's extensive experience includes work at GeneSoft Pharmaceuticals and Howard Hughes Medical Institute at UCLA. Vadim holds a Doctor of Philosophy in Biochemistry from Lomonosov Moscow State University.